Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

NCT06485947 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: Dinutuximab beta
DRUG: chemotherapy treatment called GPOH
DRUG: chemotherapy treatment called rapid COJEC

Sponsor

Princess Maxima Center for Pediatric Oncology

Collaborators

[object Object]